Skip to main content
Clinical Trials/IRCT20200303046677N5
IRCT20200303046677N5
Recruiting
Phase 3

Effect of traditional medicine product based on Rosa damascena on gastroesophageal reflux disease (GERD): a double-blind clinical trial

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
70
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • With reflux at the age of 18 to 80 years

Exclusion Criteria

  • Having a history of Barrett's esophagus
  • History of esophageal or gastric surgery
  • History of esophageal, gastric or abdominal cancer
  • Having coagulation problems that prevent them from stopping their medication
  • Patients receiving regular glucocorticoids and nonsteroidal anti\-inflammatory drugs more than three days a week for the past 28 days
  • Receiving sucralfate three days before enrollment
  • Take aspirin daily at a dose of more than 150 mg
  • Acute peptic ulcer or its complications
  • Receive antibiotic treatment to eradicate Helicobacter Pylori in the last 28 days
  • Smoking or Alcohol

Outcomes

Primary Outcomes

Not specified

Similar Trials